Why Sanofi’s Coronavirus Vaccine Work Hasn’t Helped Its Stock

 

Why Sanofi’s Coronavirus Vaccine Work Hasn’t Helped Its Stock

French drugmaker Sanofi (NASDAQ: SNY) is at the forefront when it comes to the development of a coronavirus treatment or vaccine, and yet its shares haven’t benefited from the efforts. While Sanofi …

More Why Sanofi’s Coronavirus Vaccine Work Hasn’t Helped Its Stock Videos

Leave a Reply